Julia Coronella

Title: Julia Coronella: Innovator in Monoclonal Binding Agents

Introduction

Julia Coronella is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal binding agents. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Julia's latest patents include innovative compositions that focus on specific binding agents. One of her notable patents is for "CMET monoclonal binding agents, drug conjugates thereof and uses thereof." This patent presents compositions comprising monoclonal binding agents that specifically bind to the extracellular domain of cMET, along with their various uses. Another significant patent is for "Syndecan-1 (CD138) binding agents and uses thereof," which details compositions that include binding agents specifically targeting syndecan-1.

Career Highlights

Julia Coronella is currently associated with Mitsubishi Tanabe Pharma Corporation, where she continues to push the boundaries of research and development in her field. Her work is instrumental in creating new therapeutic options that can improve patient outcomes.

Collaborations

Julia collaborates with talented professionals in her field, including Anjuli Timmer and Roland A Newman. These partnerships enhance the innovative potential of her projects and contribute to the success of her research endeavors.

Conclusion

Julia Coronella is a remarkable inventor whose work in monoclonal binding agents is making a significant impact in biotechnology. Her patents reflect her dedication to advancing medical science and improving therapeutic options for patients.